Welgene Biotech Co., Ltd. (6661) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Welgene Biotech Co., Ltd. (6661:TWSE), powered by AI.

Current Price
$16.20
Sector
Healthcare
What is the Welgene Biotech Co., Ltd. stock price forecast?

Welgene Biotech Co., Ltd. is currently trading at $16.20. View real-time AI analysis on Alpha Lenz.

What is Welgene Biotech Co., Ltd. insider trading activity?

View the latest insider trading data for Welgene Biotech Co., Ltd. on Alpha Lenz.

What is Welgene Biotech Co., Ltd.'s P/E ratio?

View Welgene Biotech Co., Ltd.'s valuation metrics on Alpha Lenz.

Welgene Biotech Co., Ltd.

TWSE · 6661
NT$16.20+0.20(+1.25%)
Ask about Welgene Biotech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Welgene Biotech Co., Ltd.'s ROE is 0.5%. Explore profitability and growth together.

Ask for details

Company Overview

Welgene Biotech Co., Ltd. is a biotechnology company based in Taipei, Taiwan, specializing in advanced genetic testing services and molecular diagnostic solutions. Established in 2003, the company operates two principal business segments: biotechnology testing and medical equipment sales. In its core testing segment, Welgene Biotech leverages technologies such as DNA microarray, next-generation sequencing, and real-time quantitative polymerase chain reaction (PCR) to provide precise laboratory testing for universities, hospitals, and pharmaceutical companies. Its medical equipment segment supplies essential diagnostic and research tools to various institutions in the health technology sector. Welgene Biotech plays a significant role in the Taiwanese healthcare and life sciences market by enabling personalized medicine and supporting clinical research initiatives. With a focus on innovation and quality, the company contributes to the broader advancement of medical science and the improvement of healthcare outcomes.

SectorHealthcare
IndustryDiagnostics & Research
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$375.94MRevenue
0.00Shares Out
0Employees

Margins

41.54%Gross
8.59%EBITDA
0.02%Operating
0.36%Pre-Tax
0.34%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

5.31%Rev 3Yr
-1.14%Rev 5Yr
-84.69%Op Inc 3Yr
-72.53%Op Inc 5Yr
-48.60%Net Inc 3Yr
-46.57%Net Inc 5Yr

Returns

0.23%ROA
0.47%ROE
0.83%ROIC

Financial Health

NT$224.33MCash & Cash Equivalents
NT$111.79MNet Debt
117.49%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Welgene Biotech Co., Ltd. (ticker: 6661) is a company listed on TWSE in the Healthcare sector (Diagnostics & Research).

The current price is 16.2 with a P/E ratio of -x and P/B of -x.

ROE is 0.47% and operating margin is 0.02%. Annual revenue is $376M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Welgene Biotech Co., Ltd. (6661) Stock Forecast 2026 $16.20 — Price, Financials & Analyst Targets | Alpha Lenz